Leukemia, Myelocytic, Acute
Information
- Disease name
- Leukemia, Myelocytic, Acute
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02158858 | Active, not recruiting | Phase 1/Phase 2 | A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis | July 16, 2014 | October 31, 2024 |
| NCT00136084 | Completed | Phase 3 | Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia | August 2002 | June 2012 |
| NCT01716793 | Completed | Phase 2 | Risk-adapted Therapy for Adult Acute Myeloid Leukemia. | September 1998 | November 2003 |
| NCT01723657 | Completed | Phase 2 | Risk Adapted Treatment for Primary Acute Myeloid Leukemia (AML) | October 2003 | March 2012 |
| NCT01756118 | Completed | Phase 1 | A Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia | June 2012 | February 7, 2020 |
| NCT00044486 | Completed | Phase 3 | Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899) | July 2002 | April 2005 |
| NCT00186381 | Completed | Phase 2 | Autologous Bone Marrow Transplantation in Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission | November 1995 | March 2007 |
| NCT00201240 | Completed | Phase 2 | Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303) | June 2005 | December 2013 |
| NCT00251368 | Completed | Phase 1 | Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia | January 1995 | September 2007 |
| NCT00286845 | Completed | Use of the MiCK Assay for Apoptosis in AML | January 2006 | December 2009 | |
| NCT00304447 | Completed | Phase 4 | Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia | April 2002 | January 2004 |
| NCT00000589 | Completed | Phase 3 | Trial to Reduce Alloimmunization to Platelets (TRAP) | August 1989 | July 1997 |
| NCT00406393 | Completed | Phase 3 | Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) | November 2006 | October 2015 |
| NCT00067002 | Completed | Phase 2 | Randomized Double Cord Blood Transplant Study | April 2003 | July 2016 |
| NCT00962767 | Completed | Phase 3 | Comparison of Two Treatments in Intermediate and High-risk Acute Promyelocytic Leukemia (APL) Patients to Assess Efficacy in 1st Hematological Complete Remission and Molecular Remission | May 2002 | December 2007 |
| NCT02140242 | Completed | Phase 3 | Comparison Between Two Dose Levels of Daunorubicin and Between One vs. Two Induction Cycles for Adult Patients With AML | April 16, 2014 | April 25, 2022 |
| NCT00393380 | Terminated | Phase 2 | Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated Donor | September 2006 | March 2012 |
| NCT00048100 | Terminated | Phase 1 | Anti-Leukemic Dendritic Cell Activated Donor Lymphocytes | February 2001 | May 2005 |
| NCT00152594 | Terminated | Phase 3 | Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia | October 2004 | January 2006 |
| NCT00446303 | Terminated | Phase 2 | A Phase II Study of Maintenance With Azacitidine in MDS Patients | July 2006 | July 2010 |
| NCT01050946 | Terminated | Phase 2 | Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit | July 2009 | March 2013 |
| NCT01339910 | Terminated | Phase 3 | Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901) | June 2011 | October 16, 2017 |
| NCT00449319 | Unknown status | N/A | AML Treatment in Untreated Adult Patients | November 1998 | July 2018 |
| NCT00126321 | Unknown status | Phase 2 | Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML) | November 2004 | March 2011 |
| NCT02895412 | Unknown status | Phase 1 | Infection and Tumour Antigen Cellular Therapy | August 2016 | December 2020 |